The National Pharmaceutical Pricing Authority (NPPA) has sent a notice to Faridabad's Metro Heart Institute, asking them to pay approximately Rs. 1.26 lakh as fine to the department of pharmaceuticals for allegedly overcharging patients for stents.
As per the statement issued by the pharmaceutical watchdog on Thursday, the hospital apparently overcharged two patients and made one pay Rs. 60,000 for a stent, while another was billed Rs. 1.25 lakh.
This came after the NPPA had on February 14 slashed the price of drug-eluting stents at Rs. 29,600 and bare metal at Rs. 7,000.
"It is reiterated that. for the implementation of a price cap, the effective date is the date of billing and not the date of angioplasty. If a patient has angioplasty done before February 14, 2017, and billed on February 14, 2017, or after, the patient will mandatorily get the benefit of the revised prices," read the notice issued by the NPPA.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
